MATERIAL TRANSFER AND CONFIDENTIALITY AGREEMENTMaterial Transfer and Confidentiality Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
Crucell Holland B.V., a dutch Company with offices located at Archimedesweg 4, 2333 CN, Leiden, the Netherlands, hereinafter referred to as “CRUCELL”; and
CRUCELL HOLLAND B.V. – VASCULAR BIOGENICS LTD. COMMERCIAL GENE THERAPY LICENSE AGREEMENTCommercial Gene Therapy License Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
This Commercial Gene Therapy License Agreement (“Agreement”) is made and entered into on April 15, 2011 (“EFFECTIVE DATE”) by and between:
TECHNICAL AGREEMENT ON THE MANUFACTURE OF CAPSULES VB-201 for VASCULAR BIOGENICSTechnical Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
AGREEMENTCollaboration Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
Tel Hashomer - Medical Research, Infrastructure and Services Ltd., a private company duly incorporated under the laws of the State of Israel having its registered office at Tel Hashomer, Israel, 52621, represented by its authorized representatives (“THM”); and
MANUFACTURING SERVICES AGREEMENTManufacturing Services Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations • England and Wales
This Manufacturing Services Agreement (the “Agreement”) is made as of January 5, 2012, (the “Effective Date”) between Lonza Houston, Inc., a Delaware corporation having its principal place of business at 8066 El Rio St., Houston, TX 77054 (“LHI”), and Vascular Biologics, Ltd., an Israeli corporation, having an office at 6 Jonathan Netanyahu St., Or Yehuda, Israel 60376 (“CLIENT”) (each of LHI and CLIENT, a “Party” and, collectively, the “Parties”).
SERVICE AGREEMENT FOR A CLINICAL STUDY CONDUCTService Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations • England
TECHNICAL AGREEMENT ON THE MANUFACTURE OF CAPSULES for VASCULAR BIOGENICSTechnical Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
MATERIAL TRANSFER AND CONFIDENTIALITY AGREEMENTMaterial Transfer and Confidentiality Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
Crucell Holland B.V., a Dutch company with offices located at Archimedesweg 4, 2333 CN, Leiden, the Netherlands, hereinafter referred to as “CRUCELL”; and
GENERAL SERVICES AGREEMENT BioClinica Agreement #40801General Services Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations • England
This General Services Agreement (this “Agreement”) effective as of the last date of signature hereof (the “Effective Date”), by and between BioClinica, Inc., a Delaware Corporation, with its principal place of business at 826 Newtown-Yardley Road, Newtown, Pennsylvania, 18940-1721 (“BIOCLINICA”) and Vascular Biogenics Ltd. with its principal place of business at 6 Jonathan Netanyahu Street, Or Yehuda, Israel 60376 (“VASCULAR BIOGENICS”). BIOCLINICA and VASCULAR BIOGENICS are individually referred to as a “Party” and collectively as the “Parties”.
CLINICAL TRIAL AGREEMENT Protocol No. VB-201-079 EudraCT No. 2012-002763-10Clinical Trial Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
This means any untoward medical occurrence in a patient or clinical trial subject administered with a medicinal product and which does not necessarily have a causal relationship with the Project.
SERVICE AGREEMENT FOR A CLINICAL STUDY CONDUCTService Agreement • July 18th, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations • England
